Back

Relationship of tafamidis binding site occupancy, transthyretin stabilization, and disease modification in tafamidis treated transthyretin amyloid cardiomyopathy patients

27 August 2022 (08:15 - 09:00)
Organised by:
Congress Presentation Part of: Chronic heart failure - Amyloidosis Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Tristan Maurer

Cambridge, Ma (United States of America)

6 More presentations in this session

Presentation thumbnail
Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis - a retrospective Austrian multicenter study
Doctor N. Verheyen (Graz, AT)
Abstract Slides
Presentation thumbnail
The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides
Presentation thumbnail
Hypertension is associated with more advanced heart failure in african americans with suspected cardiac amyloidosis
Doctor S. Manjunath (Saint Louis, US)
Abstract Slides
Presentation thumbnail
Atrial fibrillation as a prognostic factor for all-cause mortality in patients with transthyretin amyloid cardiomyopathy
Professor R. Witteles (Stanford, US)
Abstract Slides
Presentation thumbnail
Clinical characteristics, patient selection and clinical outcomes of tafamidis treatment in transthyretin amyloidosis cardiomyopathy
Doctor S. Takashio (Kumamoto, JP)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - Amyloidosis

The Event

Event poster

ESC Congress 2022

27 August 2022 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
29 June 2021
thumbnail
Congress Presentation
Effect of RNAi therapeutics patisiran and vutrisiran on orthostatic hypotension due to dysautonomia in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
26 August 2022
thumbnail
Congress Presentation
Symptom burden and clinical characteristics of patients with mutations associated with hereditary transthyretin amyloidosis: insights from referrals by cardiologists to a genetic testing programme
29 June 2021
thumbnail
Congress Presentation
Correlation between invasive and non-invasive quantification of myocardial amyloid load in cardiac transthyretin amyloidosis
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources